Displaying 1 to 20 of 152 investments
Company | Country | Date | Notes | ||
---|---|---|---|---|---|
7TM Pharma A/S |
Denmark | N/A Active |
|||
Ablynx NV |
Belgium | N/A Active |
|||
Acelrx Pharmaceuticals Inc Specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute and breakthrough pain. |
United States | N/A Active |
|||
Achaogen Inc Develops solutions to the problem of drug resistance |
United States | N/A Initial investment. Round participant. Active |
|||
Aclara Biosciences Inc Develops and distributes assay solutions for drug discovery and development |
United States | N/A Active |
|||
Adolor Corp |
United States | N/A |
|||
Aegerion Pharmaceuticals Inc |
United States | N/A Active |
|||
Aegis Lightwave Inc |
United States | 1 Mar 2006 | Series D Active |
||
Aerie Pharmaceuticals Inc |
United States | 1 Mar 2011 | Series B Active |
||
Aerovance Inc |
United States | 1 Mar 2007 | Series C Initial investment. Round participant. Active |
||
Aerovance Inc |
United States | 1 Apr 2009 | N/A Active |
||
AFx Inc |
United States | N/A |
|||
Agami Systems Inc |
United States | 21 Nov 2007 | Series C Initial investment. Round participant. Active |
||
Agensys Inc |
United States | N/A Active |
|||
Alba Therapeutics Corp |
United States | N/A Active |
|||
Angiosyn Inc |
United States | N/A |
|||
Arete Therapeutics Inc A biotechnology company, engages in the discovery and development of drugs to treat diabetes, and inflammatory and cardiovascular diseases. |
United States | 1 Nov 2008 | Series A |
||
Arrow Therapeutics Ltd |
United Kingdom | N/A |
|||
Astex Pharmaceuticals Inc Drug discovery, development and commercialization. |
United States | N/A |
|||
Astex Therapeutics Ltd |
United Kingdom | N/A |